
✓
Open
6 Dec 2016
✓
Close
8 Dec 2016
3
Allotment
—
✓
Listing
Mon, Dec 19, 2016
Price Band
₹426 to ₹428
Issue Size
3,11,16,785 shares (agg. up to ₹1,331 Cr)
Lot Size
35 Shares
Listing Date
Mon, Dec 19, 2016
✦ AI Insight
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 3.49x |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Alkem Laboratories Ltd. | Mainboard | ₹1,347.76 Cr | ₹1050 | null | ₹1,381.70 | +31.59% | ₹5,709.00 (+0.64%) |
| Sakar Healthcare Ltd. | SME | ₹14.81 Cr | ₹50 | null | ₹52.15 | +4.30% | ₹896.95 (-2.18%) |
| Kwality Pharmaceuticals Ltd. | SME | ₹6.21 Cr | ₹45 | null | ₹44.50 | -1.11% | ₹2,816.90 (+3.80%) |
| Bajaj Healthcare Ltd. | SME | ₹30.90 Cr | ₹170 | null | ₹171.50 | +0.88% | ₹372.90 (+2.15%) |
| Ganga Pharmaceuticals Ltd. | SME | ₹1.54 Cr | ₹15 | null | ₹14.50 | -3.33% | ₹12.00 (+0.00%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Pre-payment of term loans | 226.29 |
| 2 | General corporate purposes | 60.42 |
About Laurus Labs IPO
Incorporated in 2005, Laurus Labs Ltd is Hyderabad based pharmaceutical company. Laurus Labs is in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.Laurus Labs operates in four business lines:1. Generics active pharmaceutical ingredients (APIs) - The development, manufacture and sale of APIs and advanced intermediates.2. Generics finished dosage forms (FDFs) - The development and manufacture of oral solid formulations.3. Synthesis - Contract development and manufacturing services for global pharmaceutical companies.4. Ingredients - The manufacture and sale of specialty ingredients for use in the nutraceutical and cosmeceutical sectors.Key Highlights:1. Laurus Labs launched 59 products since our inception in 2005.2. Nine out of the 10 largest generic pharmaceutical companies in the world are its customers.3. Laurus Labs employed 587 scientists at our R&D center in Hyderabad and 12 scientists at R&D centre in Greater Boston USA.4. The Company owned 32 patents and had 150 pending patent applications, in several countries.5
Contact Details
Laurus Labs Ltd. AddressPlot No.21Jawaharlal Nehru Pharma CityParawadaVisakhapatnam, Andhra Pradesh, 531021+ 91 40 3980 4333secretarial@lauruslabs.comVisit Website